Showing results (241-250 of 251) with videos related to
Sort By:
Pageof 26
Journal of the American College of Cardiology|November 5, 2022
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines, Eric M Isselbacher, Ourania Preventza, et al.Journal of the American College of Cardiology|May 16, 2024
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Heather L Gornik, Herbert D Aronow, et al.The Journal of Thoracic and Cardiovascular Surgery|June 30, 2023
2022 ACC/AHA guideline for the diagnosis and management of aortic disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines, Eric M Isselbacher, Ourania Preventza, et al.The New England Journal of Medicine|April 8, 2024
Empagliflozin after Acute Myocardial InfarctionJaved Butler, W Schuyler Jones, Jacob A Udell, et al.Journal of the American College of Cardiology|February 19, 2026
2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesMark A Creager, Geoffrey D Barnes, Jay Giri, et al.Circulation|February 19, 2026
2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Mark A Creager, Geoffrey D Barnes, et al.Journal of the American College of Cardiology|April 8, 2024
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial InfarctionJacob A Udell, Mark C Petrie, W Schuyler Jones, et al.Circulation|April 6, 2024
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI TrialAdrian F Hernandez, Jacob A Udell, W Schuyler Jones, et al.JAMA Cardiology|March 19, 2020
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) TrialGuillaume Marquis-Gravel, Matthew T Roe, Holly R Robertson, et al.Journal of the American Geriatrics Society|April 21, 2023
Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationaleJacob Joseph, Nicholas M Pajewski, Rowena J Dolor, et al.Pageof 26